0 TSX News - February 28, 2024Altus Group Nominates Jim Hannon and Will Brennan to its Board of DirectorsTORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) — Altus Group Limited (ʺAltus Group” or the “Company”) (TSX: AIF), a leading provider […]Read More
0 NYSE Companies - February 28, 2024Orion Group Holdings Reports Fourth Quarter and Full Year 2023 ResultsHOUSTON, Feb. 28, 2024 (GLOBE NEWSWIRE) — Orion Group Holdings, Inc. (NYSE: ORN) (the “Company”), a leading specialty construction company, […]Read More
0 NASDAQ Companies - February 28, 2024Shoals Technologies Group, Inc. Reports Financial Results for Fourth Quarter 2023– Quarterly Revenue of $130.4 million, up 38% Year-Over-Year – – Gross Margin of 42.5% – – Net Income of $16.6 million – – Adjusted […]Read More
0 NASDAQ Companies - February 28, 2024Inari Medical Reports Fourth Quarter 2023 Financial ResultsIRVINE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a […]Read More
0 NASDAQ Companies - February 28, 2024EverQuote to Participate in Upcoming Investor ConferencesCAMBRIDGE, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) — EverQuote, Inc. (Nasdaq: EVER), a leading online insurance marketplace, today announced that […]Read More
0 NASDAQ Companies - February 28, 2024Adverum Biotechnologies to Participate in the TD Cowen 44th Annual Health Care ConferenceREDWOOD CITY, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use […]Read More
0 NASDAQ Companies - February 28, 2024Sana Biotechnology to Present at the Cowen 44th Annual Health Care ConferenceSEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for […]Read More
0 NASDAQ Companies - February 28, 2024RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial ResultsALISO VIEJO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality […]Read More
0 NASDAQ Companies - February 28, 2024Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsAnticipate 2024 Product Revenue Growth of at Least 10% vs. 2023 Excluding Enzyme Sales Related to PAXLOVID™ Recently Announced Debt […]Read More
0 NASDAQ Companies - February 28, 2024Climb Global Solutions Reports Fourth Quarter and Full Year 2023 ResultsQ4 2023 Net Sales, Net Income, Adjusted EBITDA and EPS Increase to Record Levels FY 2023 Net Sales Increased 16% to […]Read More